参考文献

2020-10-20

1: Kobayashi M. Diffuse cerebrovascular dilation: Case report of amezinium metilsulfate-induced reversible cerebral vasoconstriction syndrome. Cephalalgia. 2016 Mar;36(3):289-93. doi: 10.1177/0333102415588326. PubMed PMID: 26016487.

2: Sakakibara R, Uchiyama T, Asahina M, Yoshiyama M, Yamanishi T, Hattori T. Amezinium metilsulfate, a sympathomimetic agent, may increase the risk of urinary retention in multiple system atrophy. Clin Auton Res. 2003 Feb;13(1):51-3. PubMed PMID: 12664248.

3: Harada K, Ohmori M, Fujimura A, Ohashi K. Effect of amezinium metilsulfate on the finger skin vasoconstrictor response to cold stimulation and venoconstrictor response to noradrenaline. Jpn Circ J. 1998 Nov;62(11):824-8. PubMed PMID: 9856598.

4: Adachi N, Kondo A, Hayashi K. [A case of successful treatment of postprandial syncope with combined use of amezinium metilsulfate and dihydroergotamine mesylate]. Nihon Ronen Igakkai Zasshi. 1999 Jul;36(7):499-502. Japanese. PubMed PMID: 10536458.

5: Noma K, Miyazaki H, Anzawa R, Miyoshi K, Hayashi Y, Arino T, Nishide R, Seki S, Mochizuki S. [Effects of oral amezinium metilsulfate in patients with sick sinus syndrome]. J Cardiol. 1997 Jul;30(1):29-35. Japanese. PubMed PMID: 9253693.

6: Nambu K, Yoshida K, Kagemoto A, Matsumoto K, Miyazaki H, Hashimoto M, Esumi Y, Jin Y, Gunji S, Iwabuchi M, et al. Disposition and metabolism of [14C]-amezinium metilsulfate in rats. Arzneimittelforschung. 1988 Jul;38(7):909-18. PubMed PMID: 3207436.

7: Kita K, Hirayama K. Treatment of neurogenic orthostatic hypotension with amezinium metilsulfate, a new indirect sympathomimetic drug. Neurology. 1988 Jul;38(7):1095-9. PubMed PMID: 3386828.

8: Sannomiya K, Kudo Y, Mori T, Nakazato O, Okajima T. [A case of acute idiopathic pandysautonomia]. Rinsho Shinkeigaku. 1989 Jul;29(7):895-900. Japanese. PubMed PMID: 2805514.